Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products
NCT ID: NCT02289612
Last Updated: 2018-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2014-11-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Millet Products Study - Investigation of Glycemic Index and Satiety
NCT02075788
The Effect of Viscous Fiber on Glycemic Control in Individuals With Diabetes
NCT02629263
Effect of Fiber Composite-enriched Breads on Glycemic Responses
NCT03224806
Blood Glucose Response to Highly Viscous Polysaccharide Enriched Biscuits in Healthy and Diabetic Subjects
NCT00728143
Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus
NCT02204384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tapioca Starch - Low-Fibre
Tapoica starch pudding without added fibre
Yellow Mustard Gum Fibre
High Maltose Corn Syrup - Low-Fibre
High maltose corn syrup pudding without added fibre
Yellow Mustard Gum Fibre
Trutol Glucose Beverage (#1)
Trutol Glucose Beverage containing 50 g of glucose without added fibre. Consumed at first treatment study visit.
Yellow Mustard Gum Fibre
Trutol Glucose Beverage (#2)
Trutol Glucose Beverage containing 50 g of glucose without added fibre. Consumed at final treatment study visit.
Yellow Mustard Gum Fibre
Yellow Mustard Gum Fibre - Tapioca Starch
Yellow mustard gum fibre pudding containing tapioca starch. Fibre-enriched treatment product.
Yellow Mustard Gum Fibre
Yellow Mustard Gum Fibre - High Maltose Corn Syrup
Yellow mustard gum fibre pudding containing high maltose corn syrup. Fibre-enriched treatment product.
Yellow Mustard Gum Fibre
Soluble Flaxseed Gum Fibre - Tapioca Starch
Soluble flaxseed gum fibre pudding containing tapioca starch. Fibre-enriched treatment product.
Soluble Flaxseed Gum Fibre
Soluble Flaxseed Gum Fibre - High Maltose Corn Syrup
Soluble flaxseed gum fibre pudding containing high maltose corn syrup. Fibre-enriched treatment product.
Soluble Flaxseed Gum Fibre
Fenugreek Gum Fibre - Tapioca Starch
Fenugreek gum fibre pudding containing tapioca starch. Fibre-enriched treatment product.
Fenugreek Gum Fibre
Fenugreek Gum Fibre - High Maltose Corn Syrup
Fenugreek gum fibre pudding containing high maltose corn syrup. Fibre-enriched treatment product.
Fenugreek Gum Fibre
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yellow Mustard Gum Fibre
Soluble Flaxseed Gum Fibre
Fenugreek Gum Fibre
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-70 years
* CANRISK Questionnaire score ≥21 (brief questionnaire that identifies risk of diabetes)
* BMI ≥25 and \<40 kg/m2
* Prior use of acetaminophen
Exclusion Criteria
* Food allergies or any life-threatening allergy (food or otherwise)
* Acetaminophen allergy
* Gastrointestinal conditions or illnesses (Including, but not limited to, lactose intolerance, Celiac, Crohn's, Ulcerative Colitis (UC), Irritable Bowel Disorder (IBD))
* Serious major medical condition (i.e. renal, liver)
* Pregnant or breastfeeding
* Food Neophobia Scale score between 30 and 54 (Food Neophobia Scale is a questionnaire which is intended to screen out individuals who are unsure of consuming new products)
* TFEQ-CR \>16 (TFEQ is a questionnaire to screen for restrained eaters)
* Alcohol consumption\>4 drinks/sitting
* Medication or natural health products (NHPs) used for diabetes (glycemic control)
* Medication or NHPs contraindicated with acetaminophen
* Recent or intended significant weight loss or gain (i.e. \>4 kg in previous 3 months)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ontario Ministry of Agriculture, Food and Rural Affairs
OTHER_GOV
Natural Sciences and Engineering Research Council, Canada
OTHER
Dairy Farmers of Ontario
OTHER
Agriculture and Agri-Food Canada
OTHER_GOV
University of Guelph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alison Duncan
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alison M Duncan, Ph.D., R.D.
Role: PRINCIPAL_INVESTIGATOR
University of Guelph, Human Nutraceutical Research Unit
Amanda J Wright, Ph.D.
Role: STUDY_DIRECTOR
University of Guelph, Human Nutraceutical Research Unit
Alison M Duncan, Ph.D., R.D.
Role: STUDY_DIRECTOR
University of Guelph, Human Nutraceutical Research Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Nutraceutical Research Unit
Guelph, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200603
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
14AP003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.